SMTKPartnership•prnewswire•
Smartkem Engages Anthony Amato to Support Specific Strategic Initiatives
Sentiment:Negative (30)
Summary
(NASDAQ:SMTK) MANCHESTER, England, Sept. 2, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of transistor technology, today announced that it has engaged Anthony Amato and his firm, Bridge Associates International Pharmaceutical...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 2, 2025 by prnewswire